CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to VTRS

LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION

Phase 3
MYLAN (VTRS)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Glaucoma, Primary Open Angle (POAG)

View Full Landscape
Drug Information

Target Indication

Glaucoma, Primary Open Angle (POAG)

Clinical Trial

NCT00230763

Last updated: 12/19/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.